Edition:
India

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

18.30USD
13 Dec 2017
Change (% chg)

$0.41 (+2.29%)
Prev Close
$17.89
Open
$17.89
Day's High
$18.51
Day's Low
$17.74
Volume
72,679
Avg. Vol
64,284
52-wk High
$24.85
52-wk Low
$11.74

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.70 December 14 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4 3.46 5.40 0.50 4.00
Quarter Ending Mar-18 2 2.45 4.40 0.50 4.00
Year Ending Dec-17 4 11.60 12.91 9.20 6.56
Year Ending Dec-18 4 13.05 24.00 2.00 7.46
Earnings (per share)
Quarter Ending Dec-17 5 -0.70 -0.66 -0.77 -0.49
Quarter Ending Mar-18 3 -0.68 -0.67 -0.69 -0.48
Year Ending Dec-17 5 -2.43 -2.37 -2.49 -2.18
Year Ending Dec-18 5 -3.01 -2.78 -3.15 -2.79

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 3.06 2.39 0.67 21.87
Quarter Ending Jun-17 2.13 3.58 1.45 68.35
Quarter Ending Mar-17 2.18 2.70 0.52 23.82
Quarter Ending Dec-16 1.62 2.34 0.72 44.69
Quarter Ending Sep-16 2.97 1.55 1.43 47.93
Earnings (per share)
Quarter Ending Sep-17 -0.60 -0.62 0.02 -3.23
Quarter Ending Jun-17 -0.62 -0.56 0.06 -9.31
Quarter Ending Mar-17 -0.61 -0.54 0.07 -11.95
Quarter Ending Dec-16 -0.49 1.42 1.91 -389.80
Quarter Ending Sep-16 -0.72 -2.77 2.05 -283.39

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 3.46 3.46 3.46 3.47 4.00
Quarter Ending Mar-18 2.45 2.45 2.45 4.40 4.00
Year Ending Dec-17 11.60 11.60 11.60 12.73 6.56
Year Ending Dec-18 13.05 13.05 13.05 13.93 7.46
Earnings (per share)
Quarter Ending Dec-17 -0.70 -0.70 -0.73 -0.74 -0.49
Quarter Ending Mar-18 -0.68 -0.68 -0.67 -0.68 -0.48
Year Ending Dec-17 -2.43 -2.43 -2.43 -2.43 -2.18
Year Ending Dec-18 -3.01 -3.01 -3.03 -3.02 -2.79

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Dec-17 0 0 1 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 1 0
Year Ending Dec-18 0 0 1 0